SCHEMBL17530712

SCHEMBL17530712

CCOC(=O)c1c(-c2ccc(F)cc2)nn2cc(N(CC(=O)OC(C)(C)C)[SH](=O)=O)c(OCc3ccccc3)cc12

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 2/20 0.36
HPGD P15428 2/20 0.36
LMNA P02545 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
EGFR P00533 1/20 0.34
TP53 P04637 1/20 0.34
MMP13 P45452 1/20 0.34
PDE10A Q9Y233 2/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
F2RL3 Q96RI0 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CSNK1D P48730 1/20 0.32
TGFBR1 P36897 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2464080 0.85 LMNA (0.37) ALDH1A1KDM4EMEN1KMT2AGAA
SCHEMBL2997423 0.81 LMNA (0.38) ALDH1A1KDM4EMEN1KMT2AGAA
SCHEMBL2469793 0.81 LMNA (0.40) ALDH1A1KDM4EMEN1KMT2AGAA
SCHEMBL1936858 0.76 LMNA (0.42) ALDH1A1KDM4EMEN1KMT2AGAA
SCHEMBL2997871 0.75 BRAF (0.42) ALDH1A1KDM4EMEN1KMT2AGAA
SCHEMBL15941967 0.73 CYP19A1 (0.47) KMT2A
SCHEMBL12164724 0.73 KEAP1 (0.38) ALDH1A1LMNAEGFRCSNK1D
SCHEMBL2432818 0.73 KEAP1 (0.41) PDE10ACSNK1D
SCHEMBL15941908 0.72 CYP19A1 (0.47)
SCHEMBL1936885 0.70 CYP19A1 (0.40) ALDH1A1LMNAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331502-B1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL MYERS SQUIBB CO (US) 2016-03-02 EP disclosed